IN8bio
Developing Next-Generation Gamma-Delta T Cell Engagers and Cellular Therapies for Cancer & Autoimmune Disease
25 employees · est. 2016 · New York, United States
Marker Therapeutics, Inc.
Pioneering a Multi-Antigen Approach
20 employees · est. 2018 · Houston, United States
IN8bio is the older company (2016 vs 2018).
2 signals in the last 90 days
Side-by-Side Comparison
| Metric | IN8bio | Marker Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2016 older | 2018 |
| Headquarters | ||
| Headquarters | New York, United States | Houston, United States |
| Employees | ||
| Employees | 25 | 20 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Unknown | Grant |
| Total Funding | ||
| Total Funding | $209.96M | $98.60M |
| Funding Rounds | ||
| Funding Rounds | 8 | 5 |
| Services | ||
| Services | Not tracked yet | Development of Multi-Antigen Recognizing (MAR) T cell therapies, Clinical trials for novel therapies, Research and development in immunotherapy |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with lymphoma, Individuals with blood cancers, Patients with solid tumors, Healthcare providers, Medical researchers |
| Taxonomy | ||
| Taxonomy | Not tracked yet | Immuno-Oncology, T Cell-based Immunotherapies, Hematological Malignancies, Solid Tumor Indications, Multi-antigen Approach, Non-engineered T Cells, Tumor-associated Antigens, Cell Therapy Technology, Cost-effective Manufacturing, Reduced Toxicity, Clinical-stage Company, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Adoptive T Cell Therapy |
| Website | ||
| Website | in8bio.com | markertherapeutics.com |
About IN8bio
IN8bio is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancer. The company leverages its expertise in gamma-delta T cell biology, proprietary genetic engineering, and cell-type specific ma...
About Marker Therapeutics, Inc.
Marker Therapeutics, Inc., founded in 2018, is making significant strides in the fields of Biotechnology and Health and Wellness. Headquartered in the United States, the company is driven by the slogan "Pioneering a Multi-Antigen Approach," focusing on the development of advanced T cell-based immuno...
We will tell you when either one moves
BounceWatch watches IN8bio and Marker Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at IN8bio and Marker Therapeutics, I... — by email.
Frequently Asked Questions
Compare IN8bio with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at IN8bio on 9 Jun 2026, and Marker Therapeutics, Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.